Koninklijke Philips (NYSE:PHG – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.
Analyst Ratings
This is a breakdown of current recommendations for Koninklijke Philips and Nanovibronix, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Koninklijke Philips | 0 | 5 | 0 | 0 | 2.00 |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
Valuation and Earnings
This table compares Koninklijke Philips and Nanovibronix”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Koninklijke Philips | $20.17 billion | 1.31 | $1.01 billion | $1.36 | 19.78 |
| Nanovibronix | $1.93 million | 0.10 | -$18.18 million | ($117.28) | -0.00 |
Koninklijke Philips has higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 16.4% of Nanovibronix shares are held by institutional investors. 12.2% of Nanovibronix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
Koninklijke Philips has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.
Profitability
This table compares Koninklijke Philips and Nanovibronix’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Koninklijke Philips | 6.30% | 14.38% | 5.96% |
| Nanovibronix | -1,093.61% | -60.73% | -48.48% |
Summary
Koninklijke Philips beats Nanovibronix on 9 of the 12 factors compared between the two stocks.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.
